H S Cody1, J A Urban. 1. Department of Surgery, New York Hospital-Cornell Medical Center, New York.
Abstract
BACKGROUND: The internal mammary lymph nodes (IMN) have received little attention in recent years, yet are a well-documented site of metastasis and a major prognostic factor in early-stage breast cancer. METHODS/ RESULTS: Ten-year follow-up of the final 195 patients treated by extended radical mastectomy (ERM) in this practice (selected largely on the basis of medial tumor location, and comprising 15% of all patients treated from 1965 to 1978) found IMN+ in 24% of all cases: 36% of AX+ versus 18% of AX- patients (p = 0.0023). In a multivariate analysis, the disease-free survival impact of IMN+ (p = 0.004) was second only to axillary node involvement (p < 0.0005), and surpassed tumor size (p = 0.077). IMN+ was equally frequent for tumors less than, or greater than, 2 cm (24%), and was not significantly related to patient age. Among AX- patients, there was a twofold greater risk of recurrence or death at 10 years for IMN+ than for IMN-. Among T1N0 patients, 19.6% were IMN+. CONCLUSIONS: Failure to consider IMN status in the steadily enlarging cohort of T1N0 breast cancers may result in the undertreatment of a significant proportion of stage I patients. Systemic adjuvant therapy should be considered for T1N0 patients with central or medial tumors.
BACKGROUND: The internal mammary lymph nodes (IMN) have received little attention in recent years, yet are a well-documented site of metastasis and a major prognostic factor in early-stage breast cancer. METHODS/ RESULTS: Ten-year follow-up of the final 195 patients treated by extended radical mastectomy (ERM) in this practice (selected largely on the basis of medial tumor location, and comprising 15% of all patients treated from 1965 to 1978) found IMN+ in 24% of all cases: 36% of AX+ versus 18% of AX- patients (p = 0.0023). In a multivariate analysis, the disease-free survival impact of IMN+ (p = 0.004) was second only to axillary node involvement (p < 0.0005), and surpassed tumor size (p = 0.077). IMN+ was equally frequent for tumors less than, or greater than, 2 cm (24%), and was not significantly related to patient age. Among AX- patients, there was a twofold greater risk of recurrence or death at 10 years for IMN+ than for IMN-. Among T1N0 patients, 19.6% were IMN+. CONCLUSIONS: Failure to consider IMN status in the steadily enlarging cohort of T1N0 breast cancers may result in the undertreatment of a significant proportion of stage I patients. Systemic adjuvant therapy should be considered for T1N0 patients with central or medial tumors.
Authors: U Veronesi; N Cascinelli; M Greco; R Bufalino; A Morabito; D Galluzzo; R Conti; R De Lellis; V Delle Donne; P Piotti Journal: Ann Surg Date: 1985-12 Impact factor: 12.969
Authors: J Lacour; P Bucalossi; E Cacers; G Jacobelli; T Koszarowski; M Le; C Rumeau-Rouquette; U Veronesi Journal: Cancer Date: 1976-01 Impact factor: 6.860
Authors: J Cuzick; H Stewart; R Peto; M Baum; B Fisher; H Host; J P Lythgoe; G Ribeiro; H Scheurlen; A Wallgren Journal: Cancer Treat Rep Date: 1987-01
Authors: Boon Chua; Ivo A Olivotto; James C Donald; Allen H Hayashi; Noelle Davis; Conrad H Rusnak Journal: Can J Surg Date: 2003-08 Impact factor: 2.089
Authors: Amanda L Kong; Welela Tereffe; Kelly K Hunt; Min Yi; Taewoo Kang; Kimberly Weatherspoon; Elizabeth A Mittendorf; Isabelle Bedrosian; Rosa F Hwang; Gildy V Babiera; Thomas A Buchholz; Funda Meric-Bernstam Journal: Cancer Date: 2012-05-30 Impact factor: 6.860
Authors: Maxine S Jochelson; Lizza Lebron; Stefanie S Jacobs; Junting Zheng; Chaya S Moskowitz; Simon N Powell; Virgilio Sacchini; Gary A Ulaner; Elizabeth A Morris; D David Dershaw Journal: AJR Am J Roentgenol Date: 2015-10 Impact factor: 3.959
Authors: Wolfgang Janni; Brigitte Rack; Harald Sommer; Maren Schmidt; Barbara Strobl; Dorothea Rjosk; Elisabeth Klanner; Wiebke Thieleke; Bernd Gerber; Klaus Friese; Thomas Dimpfl Journal: J Cancer Res Clin Oncol Date: 2003-07-18 Impact factor: 4.553
Authors: Susanne H Estourgie; Omgo E Nieweg; Renato A Valdés Olmos; Emiel J Th Rutgers; Bin B R Kroon Journal: Ann Surg Date: 2004-02 Impact factor: 12.969